Results 271 to 280 of about 4,371,529 (377)
Arthritis &Rheumatology, EarlyView.Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim +5 more
wiley +1 more source
MGB2 The Utilization And Costs of Prescription Drugs in A Texas Medicaid Managed Care Pilot Program
, 1998 MT Johnsrud, KA Lawson
openalex +1 more source
Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis
Arthritis &Rheumatology, EarlyView.Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley +1 more source
Prescription patterns of drugs of systemic use by dentists [PDF]
, 1999 Lia Silva de Castilho +2 more
openalex
Field study on prescription issue for hypotensive drug in Okinawa Prefecture.
, 1999 H Yoshiwara
openalex +2 more sources
Editorial: Canadian Association on Gerontology Policy Statement: Seniors and Prescription Drugs [PDF]
, 2000 openalex +1 more source
Arthritis &Rheumatology, EarlyView.Objective The objective of this study was to investigate the effect of prophylactic trimethoprim‐sulfamethoxazole (TMP‐SMX) on the incidence of serious infections in patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Methods This multicenter cohort study was designed to emulate a target trial that studied 296 patients with ...
Yun Kyu Kim +7 more
wiley +1 more source